MRSA: Mechanism of resistance, epidemiology, risk factors, prophylaxis, therapy

被引：0

作者：

Heizmann, P. ^{[1
]}

Heizmann, W. R. ^{[2
]}

Hetzer, R. ^{[1
]}

机构：

[1] Deutsch Herzzentrtun Berlin, Augustenburger Pl 1, D-13353 Berlin, Germany

[2] Zentrum Mikrobiol & Infektiol, Berlin, Germany

来源：

ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE | 2005年 / 19卷 / 02期

关键词：

MRSA; epidemiology; risk factors; prophylaxis; therapy;

D O I：

10.1007/s00398-005-0486-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Methicillin-resistant strains of Staphylococcus aureus (MRSA) are now widespread pathogens in many countries. The increasing number of MRSA is a challenge to clinicians and health care systems. In this review, mechanism of resistance, epidemiological patterns in hospitals (H-MRSA), health care institutions (HCA-MRSA) and in the community (C-MRSA), reasons for increase, dynamic of colonization, risk of disease and mortality, guidelines in case of detection, decolonization of patients, surveillance cultures and therapeutic options are discussed.

引用

页码：78 / 88

页数：11

共 58 条

[1] Determining risk factors for methicillin-resistant Staphylococcus aureus carriage after discharge from hospital [J].

Beaujean, DJMA ;

Weersink, AJL ;

Blok, HEM ;

Frénay, HME ;

Verhoef, J .

JOURNAL OF HOSPITAL INFECTION, 1999, 42 (03) :213-218

[2] NATURAL METHICILLIN RESISTANCE IN COMPARISON WITH THAT SELECTED BY INVITRO DRUG EXPOSURE IN STAPHYLOCOCCUS-AUREUS [J].

BERGERBACHI, B ;

STRASSLE, A ;

KAYSER, FH .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (02) :179-188

[3] Linezolid for the treatment of multidrug-resistant, gram-positive infections: Experience from a compassionate-use program [J].

Birmingham, MC ;

Rayner, CR ;

Meagher, AK ;

Flavin, SM ;

Batts, DH ;

Schentag, JJ .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) :159-168

[4] Community-acquired methicillin-resistant Staphylococcus aureus in institutionalized adults with developmental disabilities [J].

Borer, A ;

Gilad, J ;

Yagupsky, P ;

Peled, N ;

Porat, N ;

Trefler, R ;

Shprecher-Levy, H ;

Riesenberg, K ;

Shipman, M ;

Schlaeffer, F .

EMERGING INFECTIOUS DISEASES, 2002, 8 (09) :966-970

[5]

Boyce JM, 1997, STAPHYLOCOCCI HUMAN

[6] Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee children's hospital [J].

Buckingham, SC ;

McDougal, LK ;

Cathey, LD ;

Comeaux, K ;

Craig, AS ;

Fridkin, SK ;

Tenover, FC .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (07) :619-624

[7] Community-adapted methicillin-resistant Staphylococcus aureus (MRSA):: Population dynamics of an expanding community reservoir of MRSA [J].

Carleton, HA ;

Diep, BA ;

Charlebois, ED ;

Sensabaugh, GF ;

Perdreau-Remington, F .

JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (10) :1730-1738

[8]

Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P565

[9] The changing epidemiology of Staphylococcus aureus? [J].

Chambers, HF .

EMERGING INFECTIOUS DISEASES, 2001, 7 (02) :178-182

[10] Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains [J].

Chang, SC ;

Hsieh, SM ;

Chen, ML ;

Sheng, WH ;

Chen, YC .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (02) :131-136

← 1 2 3 4 5 6 →